Drug level monitoring

Why your team measures how much medicine is in your blood, what antibodies to a medicine mean, and how the results are used

5 min read Updated 16 November 2026 8 sources

In short

  • Drug level monitoring (also called therapeutic drug monitoring, or TDM) measures how much of a medicine is in your blood.
  • For infliximab and adalimumab, the test can also look for antibodies, which your immune system can make against the medicine and which can stop it working.
  • Before azathioprine or mercaptopurine, everyone has a TPMT blood test to check how well their body breaks these medicines down.
  • Guidance supports drug level tests most clearly when a medicine is not working. Routine checks when you are well are less proven, and hospitals differ.
  • Never change your dose yourself because of a result. Your IBD team will explain what it means for you.
On this page
  1. What is drug level monitoring?
  2. Which medicines are checked?
  3. Why do infliximab and adalimumab need antibody tests?
  4. When is testing most useful, and do the experts agree?
  5. What might my result mean?
  6. What are TPMT and metabolite tests?
  7. Why do the regular blood tests matter?
  8. Sources

What is drug level monitoring?

Drug level monitoring is a blood test that measures how much of a medicine is in your blood. Its full name is therapeutic drug monitoring, or TDM. Crohn's & Colitis UK explains that it helps your IBD team see whether the amount you are given is right, or whether it needs changing.1

It is different from routine safety blood tests. Those check things like your blood count and liver, to catch side effects early. A drug level test asks a different question: is there enough medicine in your body to do its job?12

Which medicines are checked?

  • Anti-TNF medicines, mainly infliximab and adalimumab: levels of the medicine and antibodies against it.
  • Azathioprine and mercaptopurine (thiopurines): a TPMT enzyme test before you start, and sometimes a 'metabolite' test while you are taking them.
  • Other biologic and advanced medicines that are not anti-TNFs: a review of the 2025 BSG guidelines says there is currently no role for drug level testing with these.123

Why do infliximab and adalimumab need antibody tests?

Infliximab and adalimumab are antibody-based medicines that block a protein called TNF-alpha, which can add to inflammation in the gut. Over time, some people's immune systems start making their own antibodies against the medicine. Crohn's & Colitis UK explains that these antibodies can stop the medicine working as well, or at all.145

Crohn's & Colitis UK says that for infliximab, you may need this blood test before each dose. For adalimumab, it is done from time to time. NHS Lothian's IBD service describes its own routine. It checks infliximab and adalimumab levels 12 to 14 weeks after starting, then at least once a year. If the level is low, it also checks for antibodies. For infusions, blood can be taken at the infusion appointment. Other hospitals may use different timings.245

The 2025 BSG guidelines recommend starting infliximab and adalimumab together with a thiopurine such as azathioprine, partly to lower the chance of antibodies forming. Whether that is right for you is a decision for you and your IBD team.3

When is testing most useful, and do the experts agree?

Testing is most useful when a medicine is not working. A review of the 2025 BSG guidelines describes two situations where it may help. One is when a medicine never worked properly from the start. The other is when it worked at first but has stopped working. The guidelines include a good-practice statement that drug levels can support a decision to increase the dose. Doing this may lead to better results.3

Experts are less sure about routine checks when you are well. The same review says that checking levels routinely in people who are doing well has not consistently shown a benefit over usual care. It also notes that the ideal target levels have not yet been agreed.3

NICE's guidance is older and more cautious. Its 2016 assessment of the laboratory test kits found they showed promise, but there was not enough evidence to recommend routine use across the NHS. It said labs already using them should have specialist expertise and work closely with the treating doctors. Even so, some IBD services, such as NHS Lothian's, now build drug level checks into their routine care. So what you are offered may depend on where you are treated.26

What might my result mean?

Your IBD team will read your drug level together with your symptoms and other tests. Crohn's & Colitis UK says changes to your treatment may depend on your symptoms, your blood test results and the level of medicine in your blood. In broad terms, the BSG guideline review describes it like this:34

  • Drug level results can help support a decision to increase the dose, to try to regain control of Crohn's.
  • High levels of antibodies make it unlikely that simply giving more of the same medicine will help. Switching to a different advanced medicine should be considered instead.
  • There is no single agreed 'right' level yet.36

Crohn's & Colitis UK is clear that you must not change your dose, or stop your medicine, unless your IBD team tells you to. If you feel your medicine is not working as well as it did, tell your IBD team. Do not wait for your next routine test.45

What are TPMT and metabolite tests?

TPMT is an enzyme that helps your body break down azathioprine and mercaptopurine. If your TPMT level is low, the medicine can build up and cause serious side effects, such as stopping your bone marrow from making enough blood cells. So you will have a TPMT blood test before you start. Crohn's & Colitis UK says a low result may mean a lower dose. If the test finds no TPMT at all, these medicines are not suitable and you will be offered something else.178

South Tees Hospitals' pathology service explains that about 1 in 300 people inherit two faulty copies of the TPMT gene, and about 1 in 10 carry one. No special preparation is needed for the test, and results take about a week. A recent blood transfusion can hide a low result, so tell your team if you have had one.8

Once you are taking the medicine, your team may also measure 'thiopurine metabolites', the substances your body turns these medicines into. Crohn's & Colitis UK says this helps show whether the medicine is working, whether the dose is right, and whether you are at higher risk of side effects such as liver problems. The BSG guideline review describes drug monitoring for thiopurines as well established.13

Why do the regular blood tests matter?

Drug level checks sit alongside your routine safety bloods. With azathioprine or mercaptopurine, Crohn's & Colitis UK says you will have blood count and liver tests for as long as you take them, often every two weeks at first and later about every three months. NHS Lothian describes routine checks about every six months for people on biologics. Crohn's & Colitis UK stresses that going to these appointments is part of taking your medicine safely.247

Sources

This article is written in our own words from these sources. Each number in the text points to one of them.

  1. Crohn's & Colitis UK Tests and investigations Guide, Dec 2025 Read on the Crohn's & Colitis UK website: Tests and investigations
  2. NHS Lothian Drug Monitoring in IBD Web page, Dec 2020 Read on the NHS Lothian website: Drug Monitoring in IBD
  3. Frontline Gastroenterology (via PMC) Guideline review: 2025 British Society of Gastroenterology guidelines on inflammatory bowel disease in adults - Part 1: Crohn's disease Guide, Nov 2025 Read the paper: Guideline review: 2025 British Society of Gastroenterology guidelines on inflammatory bowel disease in adults - Part 1: Crohn's disease
  4. Crohn's & Colitis UK Infliximab Guide, Jun 2024 Read on the Crohn's & Colitis UK website: Infliximab
  5. Crohn's & Colitis UK Adalimumab Guide, Sep 2024 Read on the Crohn's & Colitis UK website: Adalimumab
  6. NICE Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (HTG401, formerly DG22) Guideline, Feb 2016 Read on the NICE website: Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (HTG401, formerly DG22)
  7. Crohn's & Colitis UK Azathioprine and mercaptopurine Guide, Jun 2024 Read on the Crohn's & Colitis UK website: Azathioprine and mercaptopurine
  8. South Tees Hospitals NHS Foundation Trust Thiopurine Methyl Transferase (TPMT) Read on the South Tees Hospitals NHS Foundation Trust website: Thiopurine Methyl Transferase (TPMT)